All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Letroz 2.5mg Tablet
Prescription Required
Salt Composition : Letrozole
Manufacturer : SUN PHARMACEUTICAL INDUSTRIES LTD
Origin of Medicine : India
5 Tablet(s) In A Strip
Introduction to Letroz 2.5mg Tablet
Letroz 2.5mg Tablet is an anti-cancer drug that belongs to the class aromatase inhibitor and contains Letrozole. It is indicated as a supportive therapy after the main therapy or first-line therapy for postmenopausal women with early and advanced breast cancer whose tumors are hormone receptor-positive. Since high amounts of estrogen are found to trigger breast cancer, this medicine reduces the levels of the female reproductive hormone by blocking the enzyme (aromatase) that is involved in the production of estrogen. This medicine aims to slow or stop the growth and/or spreading to other body parts.
Inform your physician if you have not attained menopause yet, as this medicine does not work for premenopausal women. Since this medicine tends to reduce the levels of female reproductive hormones, it is not advised for menstruating women as it is related to causing fertility issues. It is advised to keep track of your cholesterol levels as this medicine tends to elevate cholesterol levels. This medicine could also decrease bone mineral density. Hence, discuss with your physician and consider monitoring your bone parameters regularly. It is advised to use effective birth control during the treatment and at least 3 weeks after the last dose because Letroz 2.5mg Tablet can cause when it is administrated.
Uses of Letroz 2.5mg Tablet
- First and second-line treatment of postmenopausal women with hormone receptor-positive breast cancer.
- Supportive to standard treatment for postmenopausal women with early breast cancer.
- Treatment for unknown advanced breast cancer in postmenopausal women.
- Extended supportive therapy for postmenopausal women with early breast cancer who have already taken other anti-cancer medication.
Therapeutic Effects of Letroz 2.5mg Tablet
The growth of some cancers in breasts is stimulated by estrogens. Letroz 2.5mg tablet is a nonsteroidal compound that inhibits estrogen production by blocking the enzyme aromatase. This medicine reduces the tumor size and stops or slows the progression of the disease, avoiding the reoccurring of early-stage breast cancer and improving the survival rate.
Interaction of Letroz 2.5mg Tablet with other drugs
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, or herbal products you take or have taken before the treatment. Certain medications like tamoxifen and others may interact with Letroz 2.5mg and cause undesirable side effects.
More Information about Letroz 2.5mg Tablet
- Keep the tablets away from the reach of children and pets.
- Store Letroz 2.5mg Tablets at an optimal temperature not exceeding 25°C.
How to consume Letroz 2.5mg Tablet
Take the Letroz 2.5mg Tablet as your physician advises. Usually, the tablets will be taken with or without food. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.
Safety Advices for Letroz 2.5mg Tablet
Pregnancy
Letroz 2.5mg tablets are highly unsafe during pregnancy because they may cause harm to the unborn baby. Discuss with a doctor about effective contraceptive methods during the Letroz 2.5mg Tablet treatment if you still have the potential to become pregnant. It is recommended to consult your physician if you are pregnant or may be pregnancy.
Breast Feeding
It is unsafe to breastfeed your baby when taking the Letroz 2.5mg tablet. It is advised to avoid breastfeeding for at least three weeks after the last dose of the medicine.
Lungs
It is unknown whether Letroz 2.5mg tablet is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
Liver
It is unknown whether Letroz 2.5mg tablet is safe for patients with liver problems. Notify your physician if you have any liver disease before starting the treatment. Contact your doctor if you experience any liver-related symptoms.
Alcohol
It is not recommended to consume alcohol while you are on the treatment with Letroz 2.5mg tablet as it may cause serious complications.
Driving
It is not recommended to consume alcohol while you are on the treatment with Letroz 2.5mg tablet as it may cause serious complications.
Side Effects of Letroz 2.5mg Tablet
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
- Decreased red blood cells
- Decreased bone mineral density
- Fluid build up in lungs
Common:
- Swelling in the face, eyes, feet, and legs
- Hot sweats and excessive sweating
- Hypercholesterolemia (high cholesterol)
- Constipation
- Heart papilation
- Hypertension
- Diarrhea
- Loss of appetite
- Nausea and Vomiting
- Muscle pain, bone pain, and joint stiffness
- Dizziness, tiredness, and sleepiness
- Breathing difficulty
- Arthralgia
Word of Advice
Notify your doctor if you have hypersensitivity because this medication is contraindicated to such a medical condition. Inform your physician if you have osteoporosis or bone fractures, and periodic monitoring of bone mineral density is required while you are on Letroz 2.5mg tablet because this medicine can cause a decrease in the bone mineral density.
Discuss with your doctor if you are planning for pregnancy, as this medicine shall impact the reproductive potential and might lead to fertility issues. Do not consume this medicine if you are still menstruating and have not yet gone through menopause. Report to your doctor if you are tolerant to any forms of sugar, as Letrozole Tablet contains lactose ingredients. If you missed a dose, do not take a double dose for the forgotten dose. Skip the missed dose and go with regular schedule.
FAQs
Q 1. How does the Letroz 2.5mg tablet work?
Letroz 2.5mg tablet is an anti-estrogen medication. It reduces estrogen levels in your body by inhibiting the enzyme aromatase, which is responsible for estrogen production. Estrogen stimulates the growth of certain types of breast cancer in your body. Reduced estrogen production may prevent cancer from spreading.
Q 2. Can Letroz 2.5mg Tablet cause mood changes?
Mood changes, such as depression or anxiety, are not common side effects of Letroz 2.5mg Tablet. However, if you experience any changes in mood while taking Letroz 2.5mg Tablet, it's important to talk to your doctor.
Q 3. What are the serious side effects of the Letroz 2.5mg tablet?
The serious side effects do not occur in everyone; very few people experience them. The serious side effects of the Letroz 2.5mg tablet include stroke, angina, heart attack, blood clotting, cataract, osteoporosis, and fluid build-up in the lungs.
Q 4. Is it better to take Letroz 2.5mg Tablet in the morning or at night?
You can take Letroz 2.5mg Tablet in the morning, midday, or evening with or without food, but you should take it at about the same time each day.
Q 5. How often should I have my bone density checked while taking Letroz 2.5mg Tablet?
Letroz 2.5mg Tablet can increase the risk of bone fractures in some people, so it's important to have regular bone density checks while taking the medication. Your doctor will recommend how often you should have these checks.
Q 6. How long is Letroz 2.5mg Tablet taken?
The length of time a person takes Letroz 2.5mg depends on their individual situation and the recommendation of their doctor. Treatment may last for several years.
Fact Box of Letroz 2.5mg Tablet
Molecule name: Letrozole
| Therapeutic class: Aromatase Inhibitor |
Pharmacological class: Anti-Neoplastic drug | Indications: Treatment for early breast cancer in postmenopausal women |
References
- Cipla (EU) Limited, Electronic Medicines Compendium (EMC), [Revised on Oct 2021], [Accessed on 22th Mar 2023], https://www.medicines.org.uk/emc/files/pil.9957.pdf
- Novartis Pharmaceuticals Corporation, [Revised on May 2020], [Accessed on 22th Mar 2023], https://www.novartis.us/sites/www.novartis.us/files/Femara.pdf?TB_iframe=true
- HIGHLIGHTS OF PRESCRIBING INFORMATION. (n.d.). [online] www.accessdata.fda.gov. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020726s027lbl.pdf [Accessed on 22th Mar 2023].
- Edward Chu, Cancer Chemotherapy, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.
- KD Tripathi, Estrogens, Progestins and Contraceptives, Essentials of Medical Pharmacology, 8th Edition, 2019, 330-353.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
